drugset / Trial / NCT06097611

Tranexamic Acid Effect in Pediatric

NCT06097611

Phase 0 Unknown 74 enrolled Assiut University
RandomizedParallel-groupDouble-blindPrevention

Summary

The study will compare mortality and blood transfusion amounts among severely polytraumatized pediatrics who did or did not receive tranexamic acid within 3 h of injury, based on Injury Severity Score (ISS) and indicators of coagulopathy and fibrinolysis.

Timeline

Start
2023-11
Primary completion
2024-11
Completion
2024-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule

Indications

No indication recorded.